174 related articles for article (PubMed ID: 25844606)
1. Cutaneous lupus erythematosus in skin of color.
Nozile W; Adgerson CN; Cohen GF
J Drugs Dermatol; 2015 Apr; 14(4):343-9. PubMed ID: 25844606
[TBL] [Abstract][Full Text] [Related]
2. An update on clinical trials for cutaneous lupus erythematosus.
Xie L; Lopes Almeida Gomes L; Stone CJ; Faden DF; Werth VP
J Dermatol; 2024 Jul; 51(7):885-894. PubMed ID: 38491743
[TBL] [Abstract][Full Text] [Related]
3. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
[TBL] [Abstract][Full Text] [Related]
4. A review of the evidence and cost of therapies for cutaneous lupus erythematosus.
Rosen JD; Paul S; Maderal A
Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129
[TBL] [Abstract][Full Text] [Related]
5. Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature review.
Vieira ML; Marques ERMC; Leda YLA; Noriega LF; Bet DL; Pereira GAAM
Lupus; 2018 Apr; 27(5):853-857. PubMed ID: 28857716
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.
Soto JA; Melo-González F; Riedel CA; Bueno SM; Kalergis AM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142624
[TBL] [Abstract][Full Text] [Related]
7. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
8. The impact of skin damage due to cutaneous lupus on quality of life.
Verma SM; Okawa J; Propert KJ; Werth VP
Br J Dermatol; 2014 Feb; 170(2):315-21. PubMed ID: 24111880
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
Foulke G; Helm LA; Clebak KT; Helm M
FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
[TBL] [Abstract][Full Text] [Related]
10. Periorbital erythema and swelling as a presenting sign of lupus erythematosus in tertiary referral centers and literature review.
Wu MY; Wang CH; Ng CY; Kuo TT; Chang YC; Yang CH; Lin JY; Ho HC; Chung WH; Chen CB
Lupus; 2018 Oct; 27(11):1828-1837. PubMed ID: 30134759
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous lupus erythematosus: diagnosis and treatment.
Okon LG; Werth VP
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):391-404. PubMed ID: 24238695
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
Zhang YP; Wu J; Han YF; Shi ZR; Wang L
Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
[TBL] [Abstract][Full Text] [Related]
13. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
Patel J; Borucki R; Werth VP
Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].
Kuhn A; Gensch K; Ständer S; Bonsmann G
Hautarzt; 2006 Mar; 57(3):251-67; quiz 268. PubMed ID: 16501922
[TBL] [Abstract][Full Text] [Related]
15. Biological therapies in the treatment of cutaneous lupus erythematosus.
Presto JK; Hejazi EZ; Werth VP
Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic approach and treatment of cutaneous lupus erythematosus.
Sticherling M; Bonsmann G; Kuhn A
J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433
[TBL] [Abstract][Full Text] [Related]
17. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
[TBL] [Abstract][Full Text] [Related]
18. [Current diagnosis of cutaneous lupus erythematosus].
Haust M; Bonsmann G; Kuhn A
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1594-8. PubMed ID: 16823708
[TBL] [Abstract][Full Text] [Related]
19. Not Just Skin Deep: Systemic Disease Involvement in Patients With Cutaneous Lupus.
O'Brien JC; Chong BF
J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S69-S74. PubMed ID: 28941498
[TBL] [Abstract][Full Text] [Related]
20. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
Front Immunol; 2021; 12():775353. PubMed ID: 34868043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
